UK – Coronavirus (COVID-19): new dedicated Yellow Card reporting site for medicines and medical devices

Reporting to the new site will enable the MHRA to rapidly identify new and emerging side effects and medical device incidents in COVID-19 treatment, including side effects for medicines taken by patients to manage long-term or pre-existing conditions.

The Yellow Card scheme is vital in helping the MHRA monitor the safety of all healthcare products in the UK to ensure they are acceptably safe for patients and users.

The MHRA has launched a dedicated COVID-19 Yellow Card reporting site for healthcare professionals, patients, and caregivers to report easily:

  • suspected side effects associated with any medicine used in patients with confirmed or suspected COVID-19, including
    • medicines to manage long-term or pre-existing conditions
    • unlicensed medicines or medicines used off-label to treat COVID-19
  • incidents involving medical devices used in relation to COVID-19, including adverse incidents with equipment, diagnostic testing kits and software/apps

In the future, the dedicated site will enable reporting of suspected side effects associated with new medicines or vaccines authorised to treat and prevent COVID-19…